Am J Perinatol
DOI: 10.1055/a-2099-4000
Short Communication

The Impact of Maternal Obesity on Neonatal Outcomes of Pregnancies Complicated by Fetal Growth Restriction

1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island
,
Matthew Esposito
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island
,
Megan G. Lord
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island
› Author Affiliations
Funding This study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development grant 1R01HD077592, Principal Investigator: Savitz, Title: Effect of Iatrogenic Delivery at 34-38 weeks' gestation on pregnancy outcome.

Abstract

Objective This study aimed to characterize the relationship between maternal obesity, fetal abdominal size, and neonatal morbidity in pregnancies complicated by fetal growth restriction (FGR).

Study Design Pregnancies complicated by FGR, which resulted in delivery of a live, singleton, nonanomalous infant at a single center between 2002 and 2013 were identified in a large, National Institutes of Health–funded database of detailed pregnancy and delivery information extracted by trained research nurses. Pregnancies complicated by diabetes were excluded. Fetal biometry measurements from third trimester ultrasounds performed at the same institution were extracted from another institutional database. Pregnancies were divided into cohorts based on fetal abdominal circumference (AC) gestational age percentile (<10th centile, 10–29th centile, 30–49th centile, and ≥50th centile) at the ultrasound closes to the date of delivery. Obesity was defined by prepregnancy body mass index >30 kg/m2. The primary outcome was a composite of neonatal morbidity (CM) including 5-minute Apgar < 7, arterial cord pH <7.0, sepsis, respiratory support, chest compressions, phototherapy, exchange transfusion, hypoglycemia requiring treatment, or neonatal death. Outcomes were compared between women with versus without prepregnancy obesity overall and then stratified by AC cohort.

Results A total of 379 pregnancies met criteria; CM occurred in 136 (36%). Overall, there was no difference in CM between infants born to women with versus without obesity (risk ratio (RR): 1.11, 95% confidence interval: 0.79–1.56). When stratified according to AC at ultrasound closest to delivery, there was higher prevalence of CM occurring among women with prepregnancy obesity than those without prepregnancy obesity when the fetal AC was >50th or 30 to 49th centile However, these differences did not reach statistical significance.

Conclusion Our study identified no significant difference in risk of CM among growth-restricted infants of obese versus nonobese mothers, including among infants with very small AC. More research is needed to further examine the potential relationships postulated here.

Key Points

  • No significant differences in neonatal outcomes of FGR pregnancies in obese versus nonobese patients.

  • No significant differences in AC percentile distribution in FGR pregnancies in obese versus nonobese.

  • Pregnancies complicated by obesity had a higher need for cardiac support but not chest compressions.

Note

This study was presented as a poster at the 42nd Annual Scientific Meeting for the Society of Maternal Fetal Medicine, Virtual Format, January 31 to February 5, 2022.




Publication History

Received: 11 July 2022

Accepted: 21 May 2023

Accepted Manuscript online:
24 May 2023

Article published online:
19 June 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Lewandowska M. Maternal obesity and risk of low birth weight, fetal growth restriction, and macrosomia: multiple analyses. Nutrients 2021; 13 (04) 1213
  • 2 Howell KR, Powell TL. Effects of maternal obesity on placental function and fetal development. Reproduction 2017; 153 (03) R97-R108
  • 3 Foo XY, Greer RM, Kumar S. Impact of maternal body mass index on intrapartum and neonatal outcomes in Brisbane, Australia, 2007 to 2013. Birth 2016; 43 (04) 358-365
  • 4 Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol 2020; 223 (04) B2-B17
  • 5 Cody F, Unterscheider J, Daly S. et al. The effect of maternal obesity on sonographic fetal weight estimation and perinatal outcome in pregnancies complicated by fetal growth restriction. J Clin Ultrasound 2016; 44 (01) 34-39
  • 6 Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ 2017; 356: j1